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BACKGROUND: Coffee and black tea contain a mixture of compounds that have the potential to influence breast cancer risk and survival.
However, epidemiologic data on the relation between coffee and black tea consumption and breast cancer survival are sparse.
METHODS: We investigated the association between coffee and black tea consumption and survival among 3243 women with invasive
breast cancer in the Swedish Mammography Cohort. Intake was estimated using a food frequency questionnaire. Cox proportional
hazard models were used to calculate hazard ratios (HRs) and 95% confidence intervals (95% CIs).
RESULTS: From 1987 to 2010 there were 394 breast cancer-specific deaths and 973 total deaths. Coffee and black tea were not
associated with breast cancer-specific or overall mortality. Women consuming 4þ cups of coffee per day had a covariate and clinical
characteristics-adjusted HR (95% CI) of death from breast cancer of 1.14 (0.71–1.83; ptrend¼ 0.81) compared with those consuming
o1 cup per day. Women consuming 2þ cups of black tea per day had a covariate and clinical characteristics-adjusted HR (95% CI)
of death from breast cancer of 1.02 (0.67–1.55; ptrend¼ 0.94) compared with non-tea drinkers. Caffeine was also not associated with
breast cancer-specific (HR for top to bottom quartile¼ 1.06; 95% CI¼ 0.79–1.44; ptrend¼ 0.71) or overall mortality.
CONCLUSION: Our findings suggest that coffee, black tea, and caffeine consumption before breast cancer diagnosis do not influence
breast cancer-specific and overall survival.
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Coffee and black tea contain a mixture of compounds that have the
potential to influence breast cancer risk and survival. Coffee may
influence risk and progression through the inhibition of DNA
methylation (Lee and Zhu, 2006), influences on tumour differ-
entiation (Pozner et al, 1986), or alterations in sex hormone levels
(Ferrini and Barrett-Connor, 1996; Nagata et al, 1998). Black tea
has also been shown to alter sex hormone levels (Kuruto-Niwa
et al, 2000; Wu et al, 2005), and the flavonoids it contains may
have antioxidant effects (Trevisanato and Kim, 2000). Caffeine is
found in both coffee and black tea, and in rodents has been shown
to increase mammary cell differentiation (VanderPloeg et al, 1992)
and decrease tumour incidence (Petrek et al, 1985). Conversely,
caffeine has also been associated with increased mammary
tumours in animal models (Welsch et al, 1983).
Coffee consumption and breast cancer risk have been exten-
sively studied with conflicting results (Ishitani et al, 2008;
Bissonauth et al, 2009; Larsson et al, 2009a; Tang et al, 2009;
Bhoo Pathy et al, 2010; Boggs et al, 2010; Nilsson et al, 2010;
Fagherazzi et al, 2011; Gierach et al, 2011; Li et al, 2011). However,
to our knowledge, only one observational study has examined
coffee consumption and survival following breast cancer diagnosis
(Sugiyama et al, 2010), and no studies have examined black tea or
caffeine. In this study, we investigated whether pre-diagnosis
coffee, black tea, and caffeine intake were associated with breast
cancer survival among women diagnosed with invasive breast
cancer in the population-based Swedish Mammography Cohort
(SMC). We also examined whether the association between coffee,
black tea, or caffeine and survival differed by hormone receptor
status, disease stage at diagnosis, or smoking status.
MATERIALS AND METHODS
Study population
This study included 3243 participants in the SMC with invasive
breast cancer diagnosed from 1987 to 2010. Recruitment and
characteristics of this cohort have been previously described
(Wolk et al, 2006). In brief, the SMC is a population-based cohort
of 66 651 women born between 1914 and 1948 that were recruited
between 1987 and 1990 in Va¨stmanland and Uppsala counties in
central Sweden. Participants completed a baseline questionnaire
with questions regarding diet, reproductive, and other factors.
In 1997, a second questionnaire was extended to include dietary
supplements, physical activity, and smoking status, and was sent to
participants who were still alive and residing in the study area;
39 227 (70%) women returned this questionnaire. The study was
approved by the ethics committee at the Karolinska Institutet.
Histologically confirmed incident invasive breast cancer
cases were ascertained by linkage of the study cohort with the
Swedish Cancer Registry. This registry has been estimated to
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provide almost 100% complete case ascertainment (Mattsson and
Wallgren, 1984). Oestrogen receptor (ER) and progesterone
receptor (PR) status and other clinical characteristics were
obtained by reviewing pathology laboratory works logs from
Uppsala University Hospital and by linkage with the clinical
database at the Regional Oncology Centre in Uppsala. Oestrogen
and PR status, menopausal status at diagnosis, tumour size, grade,
lymph node involvement, and type of treatment were available for
B72% of the cases. More detailed information on the evaluation
of hormone receptor status in this cohort has been described
previously (Larsson et al, 2009b).
Dietary assessment
Diet was assessed using a 67-item food frequency questionnaire
(FFQ) at baseline and a 96-item FFQ in 1997. Participants were
asked how often, on average, they had consumed coffee and tea
during the previous 6 months (1987) or year (1997). Eight
responses were possible ranging from never or seldom to four or
more times per day. Decaffeinated coffee and tea were rarely
consumed in Sweden during the study period. As the majority of
tea consumed during the study period was black tea, we refer to tea
as black tea throughout the manuscript. Caffeine intake was
calculated by summing the caffeine content of coffee and tea
multiplied by the amount of consumption using values obtained
from the Swedish National Food Administration Database. The
FFQ has been previously validated among SMC participants
with correlation coefficients between the questionnaire and four
1-week dietary records of 0.6 for coffee and 0.8 for tea (A Wolk,
unpublished data, 1992).
Outcome assessment
Date of death was identified through linkage to the Swedish
National Death Registry at Statistics Sweden. Cause of death was
determined by International Classification of Diseases (ICD) codes
(ICD9 and ICD10) through linkage to the Cause of Death Registry
at the National Bureau of Health and Welfare.
Statistical analysis
Cox proportional hazard models with time since diagnosis in
months as the time scale were used to calculate hazard ratios (HRs)
and 95% confidence intervals (95% CIs) for death from breast
cancer. Participants contributed person-time from the date of breast
cancer diagnosis until death from breast cancer (primary endpoint),
death from another cause, or end of follow-up on 16 October 2010.
Secondary analyses were conducted with death from any cause as
the endpoint. Coffee consumption was categorised as o1 (refer-
ence), 1, 2–3 and X4 cups per day. Black tea consumption was
categorised as non-drinker (reference),o1, 1 cup per day, andX2
cups per day. Caffeine intake was categorised in quartiles with the
lowest quartile as the reference group. Total caloric intake and age
at diagnosis were included in all models.
Education level, marital status, menopausal status at diagnosis,
body mass index (BMI), alcohol intake, and calendar year of
diagnosis were included in all multivariable models. Additional
multivariable models were adjusted for the following clinical
characteristics: stage, grade, radiation treatment, and chemother-
apy/hormonal therapy. Additional adjustment for the clinical
covariates tumour size and number of positive lymph nodes did
not further alter the effect estimates; thus they were not included in
the final model. We also adjusted for physical activity (Holmes
et al, 2005) and smoking status among women who completed the
1997 questionnaire. Coffee and black tea were included simulta-
neously in all models. Tests for linear trend were performed by
assigning the median value of each category to each participant in
that group.
We examined whether the association between coffee, black tea,
and caffeine consumption and breast cancer survival differed by
hormone receptor status, disease stage at diagnosis, or smoking
status with a likelihood ratio test comparing the model with the
cross-product term between each exposure variable and each
potential effect modifier to the model with main effects only. All
tests of statistical significance were two-sided, and statistical
analyses were performed using SAS Version 9.2 (SAS Institute Inc.,
Cary, NC, USA).
RESULTS
During 28 676 person-years of follow-up contributed by 3243
breast cancer cases, there were 973 deaths with 394 deaths from
breast cancer. Ninety-six percentage of participants reported any
coffee consumption and seventy-three percentage reported any
black tea consumption. Among those consuming coffee or black
tea, the median consumption among the drinkers was 2.5 and 1.0
cups per day, respectively. Median caffeine consumption among all
participants was 326 mg per day. Women consuming X4 cups of
coffee per day tended to be younger, had a lower mean BMI, were
less often nulliparous, consumed more alcohol, consumed less
black tea, and were more likely to smoke than those in lower
categories of coffee intake (Table 1).
No association was observed between coffee consumption and
breast cancer-specific or overall mortality. Women consumingX4
cups of coffee per day had a covariate-adjusted HR (95% CI) of
death from breast cancer of 1.01 (0.64–1.61) compared with those
consumingo1 cup per day (ptrend¼ 0.99). Adjustment for clinical
characteristics (breast cancer stage and grade) and treatment did
not materially alter the results (1.14 (0.71–1.83); ptrend¼ 0.81).
Results were similar when death from any cause was the outcome
(Table 2). When coffee consumption was dichotomised, compar-
ing women consuming X1 cup per day to those consuming o1
cup per day there was no association with breast cancer-specific
(HR¼ 1.17; 95% CI 0.80–1.72) or overall mortality (HR¼ 1.02;
95% CI 0.81–1.29). Caffeine intake was not associated with breast
cancer-specific (HR for top (median intake 488mg per day) to
bottom (median intake 155mg per day) quartile¼ 0.99; 95%
CI¼ 0.74–1.33; ptrend¼ 0.93) or overall mortality (HR for top to
bottom quartile¼ 1.07; 95% CI¼ 0.88–1.30; ptrend¼ 0.67).
Black tea consumption was nonsignificantly inversely associated
with breast cancer-specific and overall mortality. Compared with
women consuming no black tea those consuming X2 cups per
day had a covariate-adjusted HR (95% CI) of death from breast
cancer of 0.87 (0.58–1.32; ptrend¼ 0.58) and 0.84 for total deaths
(0.64–1.09; ptrend¼ 0.39). Adjustment for clinical characteristics
and treatment attenuated the results (HR for breast-cancer
deaths¼ 1.02; 95% CI¼ 0.67–1.55; ptrend¼ 0.94 and total deaths¼
0.94; 95% CI¼ 0.72–1.23; ptrend¼ 0.88) (Table 3). When women
with any black tea consumption were compared with those with no
black tea consumption, no association was observed with breast
cancer-specific (HR¼ 0.98; 95% CI 0.78–1.22) or overall mortality
(HR¼ 0.94; 95% CI 0.82–1.09).
The associations between coffee, black tea, and caffeine intake
and mortality did not vary by hormone receptor status (Supple-
mentary Tables 1 and 2), disease stage at diagnosis, or smoking
(results not shown) (all P40.05). In addition, adjustment for ER/
PR status in the covariate and clinical characteristics model did not
materially change the results. In a sensitivity analysis that excluded
women with stage IV breast cancer, results were not materially
different. We also adjusted for physical activity and smoking status
in the subset of women who completed the 1997 questionnaire and
saw no material change in the effect estimates.
We examined dietary change following breast cancer diagnosis
among the 691 breast cancer cases who were diagnosed with breast
cancer from 1987 to 1996 and completed a FFQ in 1997 after their
Coffee, black tea, and breast cancer survival
HR Harris et al
875
& 2012 Cancer Research UK British Journal of Cancer (2012) 107(5), 874 – 878
E
p
id
e
m
io
lo
g
y
breast cancer diagnosis. Over 90% remained in the same or
adjacent category of coffee or black tea intake following their
breast cancer diagnosis. However, numbers were too small to
examine the association between post-diagnosis coffee or black tea
intake and survival in this group.
DISCUSSION
In this prospective study of Swedish women with breast cancer, we
observed no association between coffee, primarily black tea, or
caffeine intake and mortality following breast cancer diagnosis.
This lack of association was consistent across hormone receptor
subtypes, stage of diagnosis, and among both smokers and non-
smokers.
The epidemiologic data regarding the relation between coffee,
tea, and caffeine and breast cancer survival is limited. Stocks
compared age-adjusted death rates and annual consumption of tea
and coffee in 20 countries and reported a positive association
between tea and breast cancer death rates but no association
with coffee (Stocks, 1970). To our knowledge, no observational
studies have examined the association between tea or caffeine
consumption and breast cancer survival, and only one study
has examined the association with coffee consumption. Sugiyama
et al (2010) examined coffee consumption and mortality due
to all-cause, cardiovascular disease (CVD), and cancer in a
prospective cohort study in Japan. They observed an inverse
association between coffee consumption and overall and CVD
mortality, but no association with total cancer mortality or
breast cancer-specific mortality (HR (95% CI) for breast cancer-
specific mortality for 1 cup per day vs none ¼ 1.54 (0.34–6.93));
however, the breast cancer-specific results were based on only
19 deaths. Coffee intake was much lower among this population
than in Sweden, which has one of the highest consumption rates
in the world. Despite the different ranges of coffee consumption
between the two study populations, we also did not observe a
significant association between coffee intake and breast cancer
mortality.
In the SMC, we have previously reported no association between
coffee consumption and breast cancer risk and an increased risk of
overall breast cancer as well as an increased risk for ERþ /PRþ
tumours with black tea consumption (Larsson et al, 2009a). The
positive association between black tea consumption and hormone
receptor-positive breast cancer risk may indicate a role of sex
steroid hormones as in vitro studies have demonstrated that tea
catechins exhibit oestrogenic activity in low concentrations
(Kuruto-Niwa et al, 2000). The lack of association observed
between black tea consumption and mortality suggests that
consumption of black tea may influence breast cancer incidence
and survival through different mechanisms.
A limitation of our study was for the majority of our participants
we only had a pre-diagnosis assessment of diet and thus had
limited power to examine diet post diagnosis during the follow-up
period. Among a cohort of breast cancer patients in the United
Kingdom, small but statistically significant changes in pre- to post-
diagnosis intake of coffee (pre-diagnosis mean 1.05 servings per
day and post-diagnosis mean 0.96 servings per day) and tea
(pre-diagnosis mean 1.55 servings per day and post-diagnosis
mean 1.61 servings per day) were observed (Velentzis et al, 2011).
However, 90% of our participants who completed an FFQ post
diagnosis remained in the same or adjacent category of coffee
and black tea consumption following diagnosis. In addition, other
dietary or lifestyle factors may have changed following breast
cancer diagnosis. Studies have shown that younger women are
most likely to report these changes and the average age at breast
cancer diagnosis in our cohort was 65.1 years (Salminen and
Lagstrom, 2000; Maunsell et al, 2002). Coffee and black tea
consumption were assessed with a self-administered FFQ, which is
subject to some measurement error and could have resulted in
attenuation of the true association. However, in this cohort the
FFQ has been validated using diet records with correlations of 0.6
for coffee and 0.8 for tea (A Wolk, unpublished data, 1992). Finally,
residual or unmeasured confounding by lifestyle or other dietary
factors that are associated with coffee and/or tea consumption is
a possibility. However, we adjusted for a number of potential
confounders including smoking status, and the association did not
materially change.
To our knowledge, this is the largest study among women with
breast cancer to examine the association between coffee consump-
tion and mortality, and the first study to examine the association
with primarily black tea and caffeine. With 973 total deaths,
including 394 breast cancer deaths, we had the ability to examine
breast cancer-specific mortality as well as how the associations
Table 1 Characteristics of 3234 women with invasive breast cancer in
the Swedish Mammography Cohort by coffee intakea
Coffee intake
(cups per day)
o1 1 2–3 X4
Median coffee intake (g per day) 12 177 443 768
Age at enrollment (years) 52.4 56.1 53.1 48.5
Age at diagnosis (years) 65.6 68.6 65.8 62.1
Post-secondary education (%) 16.8 14.3 13.0 14.4
Married (%) 65.3 68.6 71.7 71.3
Body mass index (kgm 2) 25.2 25.2 24.9 24.7
Height (cm) 165.3 164.9 164.5 165.1
Age at menarche (years) 13.2 13.3 13.2 13.1
Nulliparous (%) 14.2 17.5 11.7 11.2
Age at first birth among parous women (years) 24.6 24.9 24.8 23.7
Number of children 2.3 2.3 2.2 2.4
Family history of breast cancer (%) 10.6 13.9 10.7 9.5
Ever use of oral contraceptives (%) 58.7 48.6 55.8 63.7
Ever use of postmenopausal hormones (%) 46.8 51.3 45.8 47.1
Postmenopausal at diagnosis (%) 91.2 94.6 91.2 89.2
Alcohol intake (grams per day) 2.2 2.4 2.9 3.4
Current smoker (%)b 5.9 5.8 11.8 24.8
Past smoker (%)b 32.5 31.0 33.6 43.3
Tea intake (cups per day) 1.3 0.9 0.5 0.3
Caffeine intake (mg per day) 105.5 175.1 338.7 523.1
Total energy intake (kcal per day) 1532 1498 1587 1688
Disease stage (%)c,d
Stage I 51.7 50.2 52.5 54.1
Stage II 42.9 42.2 40.0 39.7
Stage III/IV 3.9 6.9 5.5 5.2
Treatment (%)d,e
Radiation 56.6 48.2 52.3 56.6
Chemotherapy 21.2 12.3 13.1 17.2
Hormonal 33.6 33.9 32.1 32.1
Oestrogen receptor positive (%)d 79.7 83.0 81.4 81.7
Progesterone receptor positive (%)d 67.2 70.4 66.5 65.4
Tumour size (%)d
o2 cm 66.0 59.5 60.9 63.7
2–4 cm 28.1 33.2 33.3 29.6
44 cm 5.9 7.2 5.7 6.6
Number of positive-lymph nodes (%)d
None 57.6 63.8 65.6 65.3
1–3 27.3 25.8 22.9 23.2
X4 15.1 10.5 11.6 11.5
aData represent mean unless otherwise indicated. bSmoking status was only available
from women (n¼ 2110) who completed the 1997 questionnaire. cPercentages may
not equal 100 owing to missing values. dInformation on clinical characteristics was
available for B72% of the participants. eGreater than 100% because some breast
cancer patients received more than one treatment.
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differed by tumour hormone receptor status. We had 80% power
to detect hazards ratios of 1.38. We also have complete follow-up
of all cases, a long follow-up period, detailed information on diet,
and data on many important covariates, including clinical and
lifestyle characteristics.
In conclusion, among a population of Swedish women with high
coffee consumption, we did not observe an association between
coffee, black tea, or caffeine consumption and breast cancer-
specific survival or overall survival.
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